I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

We nominate Jessica MacIntyre for the 2025 Extraordinary Healer Award for Oncology Nursing for her personal, local and ...

Panelists discuss balancing clinical trial data with real-world patient factors when choosing between treatment options, emphasizing the importance of quality of life alongside cancer control in the ...

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...

Dr. Daniel J. Boffa discusses the link between smoking cessation and increase in survival for people who are active smokers and diagnosed with cancer.

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma ...

After 30 years with breast cancer, I urge others to pause, reflect and choose care based on long-term wellbeing, not fear or ...